enGene (Nasdaq: ENGN) Launched as Publicly Traded Genetic Medicines Company

2023

Nov 1

Written By Guest User

Guest User

Amolyt Pharma Named ‘Biotech Company of the Year’ at the LSX European Lifestars Awards

Ironwood Enters into Definitive Agreement to Acquire VectivBio